0001683168-26-007206 Sample Contracts
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 17th, 2026 • Aethlon Medical Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledSeptember 17th, 2026 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of September 17, 2026, by and among North Immunology Inc., a Delaware corporation (the “Company”), and each of the Persons listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).
FORM OF LOCK-UP AGREEMENTLock-Up Agreement • September 17th, 2026 • Aethlon Medical Inc • Surgical & medical instruments & apparatus
Contract Type FiledSeptember 17th, 2026 Company IndustryThe undersigned signatory of this lock-up agreement (this “Lock-Up Agreement”) understands that Aethlon Medical, Inc., a Nevada corporation (“Parent”), has entered into an Agreement and Plan of Merger and Reorganization, dated as of September 17, 2026 (as the same may be amended from time to time, the “Merger Agreement”) with Nighthawk Merger Sub Corp., a Delaware corporation and a wholly owned subsidiary of Parent, Nighthawk Second Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary of Parent, and North Immunology Inc., a Delaware corporation (the “Company”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement.
FORM OF CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • September 17th, 2026 • Aethlon Medical Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledSeptember 17th, 2026 Company Industry JurisdictionThis CONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”), dated as of [__], 2026, is entered into by and among Aethlon Medical, Inc., a Nevada corporation (the “Company”), [__], a [__], as the “Rights Agent” (as defined herein), and Nicolas Gikakis, an individual, solely in his capacity as the initial representative, agent and attorney in fact of the Holders (the “Representative”).
FORM OF PARENT SUPPORT AGREEMENTParent Support Agreement • September 17th, 2026 • Aethlon Medical Inc • Surgical & medical instruments & apparatus • Nevada
Contract Type FiledSeptember 17th, 2026 Company Industry JurisdictionThis Support Agreement (this “Agreement”) is made and entered into as of September 17, 2026, by and among North Immunology Inc., a Delaware corporation (the “Company”), Aethlon Medical, Inc., a Nevada corporation (“Parent”), and the undersigned stockholder of Parent (the “Stockholder” and each of the Stockholder, Company, and Parent, a “Party” and, collectively, the “Parties”). Capitalized terms used herein but not otherwise defined shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).
FORM OF PRE-FUNDED WARRANT TO PURCHASE COMMON STOCKWarrant Agreement • September 17th, 2026 • Aethlon Medical Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledSeptember 17th, 2026 Company Industry JurisdictionThis Warrant is one of a series of similar warrants issued pursuant to that certain Securities Purchase Agreement, dated September 17, 2026, by and among the Company and the Investors identified therein (the “Purchase Agreement”). Capitalized terms used and not defined herein shall have the meaning set forth in the Purchase Agreement.
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: Aethlon Medical, Inc.; Nighthawk MERGER SUB CORP.; Nighthawk SECOND MERGER SUB, LLC; and North Immunology, Inc. Dated as of September 17, 2026Merger Agreement • September 17th, 2026 • Aethlon Medical Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledSeptember 17th, 2026 Company Industry Jurisdiction
FORM OF COMPANY SUPPORT AGREEMENTSupport Agreement • September 17th, 2026 • Aethlon Medical Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledSeptember 17th, 2026 Company Industry JurisdictionThis Support Agreement (this “Agreement”) is made and entered into as of September 17, 2026, by and among North Immunology Inc., a Delaware corporation (the “Company”), Aethlon Medical, Inc., a Nevada corporation (“Parent”), and the undersigned stockholder of the Company (the “Stockholder” and each of the Stockholder, Company, and Parent, a “Party” and, collectively, the “Parties”). Capitalized terms used herein but not otherwise defined shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).
